Sensorium Therapeutics – Modern Neuroscience Technology Meets Ethnobotanical History for the Development of Mental Health Therapeutics

Dick Simon is co-founder and CEO of Sensorium Therapeutics, a drug discovery platform translating insights from nature and modern neuroscience to develop novel mental health therapeutics. The search for natural compounds with medicinal value is an underexplored area in the advancement of clinical-grade medicines. Dick talks about Sensorium’s proprietary drug discovery platform, which has created better tools to address these unique technical challenges with machine learning and through a significant library of psychoactive plants to pinpoint realistic drug candidates targeting mental health. 

Dick Simon, Co-Founder & CEO. ​​Dick is a serial entrepreneur and leader in advancing psychedelic-assisted therapies. He is the Chairman of the Advisory Council of Center for the Neuroscience of Psychedelics at Massachusetts General Hospital, Co- Founder and Board Member of the Boston Psychedelic Research Group, and on the steering committee for the Psychedelic Science Funders Collaborative. Dick received his undergraduate degree from Cornell University and his MBA from Harvard Business School. After September 11, 2001, Dick co-founded and led the YPO Peace Action Network which leverages personal and business relationships, resources, and expertise for conflict resolution on local and global levels. Dick’s work has earned him YPO’s Global Humanitarian Award, Harvard Business School’s Making a Difference Award, inclusion in Real Leaders magazine’s “100 Visionary Leaders” and in the “100 Most Influential People in Psychedelics” list.

Liked it? Take a second to support healthprofessionalradio on Patreon!


Leave a Reply

You must be logged in to post a comment.